作者: B. Maisch , G. Hufnagel , S. Pankuweit , M. Herzum , U. Schönian
DOI: 10.1007/978-88-470-2155-6_25
关键词:
摘要: Controversy still exists on whether immusuppressive treatment is beneficial in myocarditis. This contribution examines the immunologic rationale for immunosuppressive therapy inflammatory dilated cardiomyopathy by revisiting currently available data man and experimental animals.